A CDC study showed Tennessee was among 13 states with the highest prevalence of suspected cases of Alpha-gal syndrome.
The Alpha-1 Antitrypsin Deficiency Disease market offers opportunities in developing targeted therapies due to an increasing diagnosed patient population, advances in genetic testing, and innovative ...
CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming ...
Q3 2025 Management View CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with the expected FDA authorization of GraftAssureDx, ...
In Brief Alpha Test Commences for Pet Raiders Oh Baby Games has announced the commencement of the application process for the ...
New cross-functional "Alpha Labs" team will fast-track AI and automation capabilities from concept to product, helping long-term care pharmacies work smarter, faster, and more efficiently. PITTSBURGH, ...
AI Brokers, a next-generation investment platform fusing conversational artificial intelligence with stock trading, has launched its Alpha version in a ...
The mines where one mine worker was left dead Nov. 6, 2025 and another has been the target of an underground rescue mission ...
One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, ...